B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ruxolitinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ruxolitinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

su
112 shared targets
fedratinib
117 shared targets
tae
116 shared targets
r
107 shared targets
kw
113 shared targets
nintedanib
91 shared targets
lestaurtinib
124 shared targets
dovitinib
79 shared targets
midostaurin
86 shared targets
pha
70 shared targets
Loading evidence profile...

This evidence profile for Ruxolitinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.